Income before deduction of interest, taxes and amortization: Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO) has earned physician recognition by developing selective drugs designed to protect healthy tissues. The EBITDA_Co valuation demonstrates a peak in activity, where 0.00 determines the current magnitude of the metric. Xilio Therapeutics, Inc. (XLO) minimizes risks through the diversification of its immunotherapeutic portfolio targeting various tumors. Simultaneously, the company is implementing software robots and automated screening to accelerate drug development.
Summary analytical data breakdowns for Xilio (XLO)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- business debt structure and liquidity details:
- earnings and market multiples details:
XLO - Net Income|Future Net Profit Xilio Therapeutics, Inc.|XLO - P/E Multiple|Future Price to Earnings Multiple Xilio|XLO - PEG Multiple|Company Value to EBITDA Xilio Therapeutics Inc|XLO - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Xilio Therapeutics|XLO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth xiliotx.com|XLO - Earnings per share growth in current year|Net earnings per share change forecast for next year Xilio Therapeutics, Inc.
- sales and revenue indicators:
Summary company analytics:XLO Xilio Therapeutics
To identify fundamental benchmarks, investors must analyze the business's ability to generate earnings before interest, taxes, depreciation, and amortization. This metric measures net operating income, which serves as the basis for valuing Xilio Therapeutics, Inc. (XLO); by analyzing aggregated EBITDA, one can understand how screening robotization and data automation impact the company's actual profitability and scaling rates.
Competitors of Xilio Therapeutics, Inc. (XLO)
Operating profit EBITDA beigene.com ONC|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Corp - Income before deduction of interest, taxes and amortization|URGN (UroGen Pharma Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Therapeutics Inc. BCAX|Profit before payment of interest, taxes and amortization Personalis, Inc. (PSNL)|ERAS - Profit before interest, taxes and amortization|Operating profit EBITDA DCTH (delcath.com)|Operating profit before depreciation charges Y-mAbs Corp|AURA - Profit before payment of interest, taxes and amortization|CADL (candeltx.com) - Operating profit before amortization|ARAY (accuray.com) - Operating profit before deduction of amortization|SELLAS Life Sciences Group Inc. (SLS) - Operating profit EBITDA|ACTU (Actuate Therapeutics Inc.) - Operating profit EBITDA|Operating profit EBITDA Citius Oncology Inc|Operating profit EBITDA HURA|TARA (Protara Therapeutics) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA FATE (Fate Therapeutics)|Operating income before deduction of amortization Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Operating profit EBITDA|CSBR (Champions Oncology, Inc.) - Operating profit before amortization|XBIT (XBiotech USA) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Radiopharm Theranostics (RADX)|Operating profit before deduction of amortization ARTV (Artiva Biotherapeutics, Inc.)|ANL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Veru Inc. VERU|Income before deduction of interest, taxes and amortization TPST|RENB: Operating profit before deduction of amortization|Operating profit before depreciation charges Mural Oncology PLC (MURA)|KAPA (Kairos Pharma Inc) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization OnKure Therapeutics Inc (OKUR)|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization Curis, Inc. (CRIS)|Operating profit EBITDA APLM|Company profit before taxes, interest and amortization THAR|Operating profit EBITDA ADVB (advanbiomed.com)|GNPX - Operating profit before deduction of amortization|CLDI: Operating profit before deduction of amortization|SBFM - Operating profit EBITDA|Xenetic Biosciences (XBIO) - Profit before payment of interest, taxes and amortization|SLRX: Company profit before taxes, interest and amortization|PPBT (Purple Biotech Ltd) - Operating profit EBITDA|Profit before interest, taxes and amortization American Oncology Network, Inc. AONC|Operating profit EBITDA BGNE|Operating income before deduction of amortization Checkpoint Therapeutics|Elevation Oncology, Inc. - Operating profit before deduction of amortization|Operating profit EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Operating profit EBITDA|NTBL - Operating profit EBITDA|VIRX (Viracta Therapeutics) - Operating profit before deduction of amortization|MorphoSys AG - Income before deduction of interest, taxes and amortization|NAYA (NAYA Biosciences Corp) - Operating profit EBITDA|Operating profit EBITDA Ascentage Pharma Group International
